Kanada - Inggris - Health Canada

hikma canada limited - fentanyl (fentanyl citrate) - solution - 50mcg - fentanyl (fentanyl citrate) 50mcg - opiate agonists

Kanada - Inggris - Health Canada

pro doc limitee - fentanyl - patch - 12mcg - fentanyl 12mcg - opiate agonists

Kanada - Inggris - Health Canada

pro doc limitee - fentanyl - patch - 25mcg - fentanyl 25mcg - opiate agonists

Kanada - Inggris - Health Canada

pro doc limitee - fentanyl - patch - 50mcg - fentanyl 50mcg - opiate agonists

Kanada - Inggris - Health Canada

pro doc limitee - fentanyl - patch - 75mcg - fentanyl 75mcg - opiate agonists

Kanada - Inggris - Health Canada

pro doc limitee - fentanyl - patch - 100mcg - fentanyl 100mcg - opiate agonists

Amerika Serikat - Inggris - NLM (National Library of Medicine)

cima labs inc. - fentanyl citrate (unii: mun5lyg46h) (fentanyl - unii:uf599785jz) - fentanyl 200 ug

Amerika Serikat - Inggris - NLM (National Library of Medicine)

sentynl therapeutics, inc. - fentanyl citrate (unii: mun5lyg46h) (fentanyl - unii:uf599785jz) - fentanyl 100 ug - abstral® is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving, and who are tolerant to, around-the-clock opioid therapy for their underlying persistent cancer pain. patients considered opioid tolerant are those who are taking around-the-clock medicine consisting of at least 60 mg of oral morphine per day, or at least 25 mcg per hour of transdermal fentanyl, or at least 30 mg of oral oxycodone per day, or at least 8 mg of oral hydromorphone per day, or at least 25 mg oral oxymorphone per day, or at least 60 mg oral hydrocodone per day or an equianalgesic dose of another opioid medication daily for a week or longer. patients must remain on around-the- clock opioids when taking abstral® . limitations of use : - not for use in opioid non-tolerant patients. - not for use in the management of acute or postoperative pain, including headache/migraine, dental pain, or in the emergency department [see contraindications (4)]. - as a part of the tirf

Amerika Serikat - Inggris - NLM (National Library of Medicine)

par pharmaceutical inc. - fentanyl citrate (unii: mun5lyg46h) (fentanyl - unii:uf599785jz) - fentanyl 200 ug

Amerika Serikat - Inggris - NLM (National Library of Medicine)

galena biopharma, inc. - fentanyl citrate (unii: mun5lyg46h) (fentanyl - unii:uf599785jz) - fentanyl 100 ug - abstral (fentanyl) sublingual tablets are indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. patients considered opioid tolerant are those who are taking around-theclock medicine consisting of at least 60 mg of oral morphine daily, or at least 25 mcg of transdermal fentanyl/hour, or at least 30 mg of oral oxycodone daily, or at least 8 mg of oral hydromorphone daily or at least 25 mg oral oxymorphone daily, or an equianalgesic dose of another opioid medication daily for a week or longer. patients must remain on around-the-clock opioids when taking abstral . abstral is contraindicated for patients who are not already tolerant to opioids because life-threatening respiratory depression and death could result at any dose in patients not on a chronic regimen of opioids. for this reason, abstral is contraindicated in the management of acute or postoperative pain,